Evaluation of Neointimal Hyperplasia on Tranilast-Coated Synthetic Vascular Grafts: An Experimental Study

REFERENCES

• Lemson M S, Tordoir J H, Daemen M J, Kitslaar P J. Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg. 2000; 19(4)336–350, Review. No abstract available
   PubMed Web of Science ®Google Scholar
• Goldman S, Zadina K, Krasnicka B, et al. Predictors of graft patency 3 years after coronary artery bypass graft surgery. Department of Veterans Affairs Cooperative Study Group No. 297. J Am Coll Cardiol. 1997; 29(7)1563–1568
   PubMed Web of Science ®Google Scholar
• Watase M, Kambayashi J, Itoh T, et al. Ultrastructural analysis of pseudo-intimal hyperplasia of polytetrafluoroethylene prostheses implanted into the venous and arterial systems. Eur J Vasc Surg. 1992; 6(4)371–380
   PubMedGoogle Scholar
• Clowes A W. Intimal hyperplasia and graft failure. Cardiovasc Pathol 1993; 2: 179S–186S, Suppl
   Web of Science ®Google Scholar
• Golden M A, Au Y P, Kirkman T R, et al. Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons. Association in vivo of platelet-derived growth factor mRNA and protein with cellular proliferation. J Clin Invest. 1991; 87(2)406–414
   PubMed Web of Science ®Google Scholar
• Clowes A W, Gown A M, Hanson S R, Reidy M A. Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol. 1985; 118(1)43–54
   PubMed Web of Science ®Google Scholar
• Tamai H, Katoh O, Suzuki S, et al. Impact of tranilast on restenosis after coronary angioplasty: Tranilast restenosis following angioplasty trial (TREAT). Am Heart J. 1999; 138: 968–975, 5 Pt 1
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Kikuchi S, Fukuyama J, Hamano S, Ujiie A. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 1995; 118(2)213–221
   PubMed Web of Science ®Google Scholar
• Fukuyama J, Miyazawa K, Hamano S, Ujiie A. Inhibitory effects of tranilast on proliferation, migration, and collagen synthesis of human vascular smooth muscle cells. Can J Physiol Pharmacol. 1996; 74(1)80–84
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Fukuyama J, Misawa K, Hamano S, Ujiie A. Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells. Atherosclerosis. 1996; 121(2)167–173
   PubMed Web of Science ®Google Scholar
• Hishikawa K, Nakaki T, Hirahashi J, Marumo T, Saruta T. Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells. J Cardiovasc Pharmacol. 1996; 28(2)200–207
   PubMed Web of Science ®Google Scholar
• Fukuyama J, Ichikawa K, Miyazawa K, Hamano S, Shibata N, Ujiie A. Tranilast suppresses intimal hyperplasia in the balloon injury model and cuff treatment model in rabbits. Jpn J Pharmacol. 1996; 70(4)321–327
   PubMedGoogle Scholar
• Fukuyama J, Ichikawa K, Hamano S, Shibata N. Tranilast suppresses the vascular intimal hyperplasia after balloon injury in rabbits fed on a high-cholesterol diet. Eur J Pharmacol. 1996; 318(2–3)327–332
   PubMed Web of Science ®Google Scholar
• Ichikawa K, Fukuyama J, Miyazawa K, et al. Suppressive effect of an anti-allergic drug, tranilast on the vascular intimal thicking by balloon catheter. Pharmacometrics. 1995; 50: 539–545
   Google Scholar
• Kikuchi S, Umemura K, Kondo K, Nakashima M. Tranilast suppresses intimal hyperplasia after photochemically induced endothelial injury in the rat. Eur J Pharmacol. 1996; 295(2–3)221–227
   PubMed Web of Science ®Google Scholar
• Ishiwata S, Choronos N AF, Lin G, et al. Tranilast inhibits neointimal formation in balloon-injured and stented pig coronary arteries and decreases negative remodelling after injury. J Am Coll Cardiol. 1998; 31: 144, (Abstract)
   PubMed Web of Science ®Google Scholar
• Tamai H, Katoh K, Yamaguchi T, et al. The impact of tranilast on restenosis after coronary angioplasty: The Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2). Am Heart J. 2002; 143(3)506–513
   PubMed Web of Science ®Google Scholar
• Jackson M R, Belott T P, Dickason T, et al. The consequences of a failed femoropopliteal bypass grafting: Comparison of saphenous vein and PTFE grafts. J Vasc Surg. 2000; 32(3)498–504; 504–505
   PubMed Web of Science ®Google Scholar
• Nolan K D, Benjamin M E, Murphy T J, et al. Femorofemoral bypass for aortofemoral graft limb occlusion: A ten-year experience. J Vasc Surg. 1994; 19(5)851–856, discussion 856–857
   PubMed Web of Science ®Google Scholar
• Lin P H, Chen C, Bush R L, Yao Q, Lumsden A B, Hanson S R. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. J Vasc Surg. 2004; 39(6)1322–1328
   PubMed Web of Science ®Google Scholar
• Cagiannos C, Abul-Khoudoud O R, De Rijk W, et al. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. J Vasc Surg. 2005; 42(5)980–988
   PubMed Web of Science ®Google Scholar
• Kosuga K, Tamai H, Ueda K, et al. Effectiveness of tranilast on restenosis after directional coronary atherectomy. Am Heart J. 1997; 134(4)712–718
   PubMed Web of Science ®Google Scholar
• Tamai H, Katoh O, Suzuki S, et al. Impact of tranilast on restenosis after coronary angioplasty: Tranilast restenosis following angioplasty trial (TREAT). Am Heart J. 1999; 138(5 Pt 1)968–975
   PubMed Web of Science ®Google Scholar
• Ward M R, Sasahara T, Agrotis A, Dilley R J, Jennings G L, Bobik A. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries. Atherosclerosis 1998; 137(2)267–275
   PubMed Web of Science ®Google Scholar
• Smith J D, Bryant S R, Couper L L, et al. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth. Circ Res. 1999; 84(10)1212–1222
   PubMed Web of Science ®Google Scholar
• Tsuji T, Tamai H, Igaki K, et al. Biodegradable stents as a platform to drug loading. Int J Cardiovasc Intervent. 2003; 5(1)13–16, Review
   PubMedGoogle Scholar
• Ward M R, Agrotis A, Kanellakis P, Hall J, Jennings G, Bobik A. Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting. Arterioscler Thromb Vasc Biol. 2002; 22(6)940–948
   PubMed Web of Science ®Google Scholar
• Shiota N, Okunishi H, Takai S, et al. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery. Circulation. 1999; 99(8)1084–1090
   PubMed Web of Science ®Google Scholar
• Lafont A, Faxon D. Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?. Cardiovasc Res. 1998; 39(1)50–59, Review. No abstract available
   PubMed Web of Science ®Google Scholar